Medcool's RapidCool technology:
This article was originally published in Clinica
Medcool has received US FDA 510(k) clearance to market its noninvasive RapidCool system for reducing head and body temperature where clinically indicated - eg in hyperthermic patients. The device uses a patented disposable helmet that directs agitated cold water to the scalp, plus standard body and neck pads to rapidly cool the head and body. It reduces temperature to a set point in the range of 32-37 degrees C, and does not interfere with other hospital procedures such as cardiac catheterisation. A growing body of research indicates that mild hypothermia, in the range of 32-34 degrees C, could have a protective effect, reducing damage from cardiac arrest, stroke, brain injury and other traumatic events, said the Wellesley, Massachusetts firm.
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.